Faze Three Limited
NSE: FAZE3QMarket Closed • NSE
Day range
52 week range
Faze Three Limited closed at INR417.80 (+2.88%) on volume 1.88x its 20-day average, trading 35.73% below its 52-week high.
2026-Q2
Q2 FY2026 Financial Results
PAT moved -50.8% QoQ
2024-09-19
AGM Announced
Annual General Meeting
2023-09-20
AGM Announced
Annual General Meeting
Revenue and PAT bars use independent scales to make their year-on-year direction readable.
Complete reported financial history · Values use the company's reporting currency
Hover over the chart for exact reported values. Percentage lines use the right-hand axis.
A 0–100 quantitative summary of reported fundamentals. Use the underlying financials and risks for context; the score is not a buy or sell recommendation.
Strengths
High Cash Flow Conversion: CFO/PAT averaged 1.19x over last 3 years
Risks
Subject to cyclical raw material and macro industry pressures
Bull case
Market Leadership: Established operational scale in Textile Manufacturing.
Bear case
Macro Headwinds: Fluctuations in interest rates and sector-specific policy shifts could compress multiples.
Flip condition
Sustained quarterly EBITDA margin expansion above 20% would trigger an upgrade.
Ownership distribution
Category trends
Hover over a period for exact holdings
Complete dividend, bonus, split, rights and other action history
| Record date | Corporate action | Information | Announcement date | Ex-date |
|---|---|---|---|---|
| — | Annual General Meeting | Annual General Meeting | — | 19 Sept 2024 |
| — | Annual General Meeting | Annual General Meeting | — | 20 Sept 2023 |
Traded volume and delivery percentage across the latest 20 sessions
Compare valuation, latest quarterly performance and year-on-year growth
| Company name | Market cap ₹ Cr | P/E ratio | Dividend yield % | Quarterly sales ₹ Cr | Profit after tax ₹ Cr | Sales growth % | Profit growth % |
|---|---|---|---|---|---|---|---|
 Titan Company LimitedTITAN Open analysis | ₹3.94L | 68.51 | 0.34% | ₹21,356.00 | ₹1,777.00 | +29.25% | +62.88% |
 Maruti Suzuki India LimitedMARUTI Open analysis | ₹3.61L | 25.20 | 1.22% | ₹52,470.00 | ₹3,447.00 | +35.92% | -9.10% |
Mahindra & Mahindra LimitedM&M Open analysis | ₹3.51L | 17.78 | 1.15% | ₹41,959.00 | ₹3,685.00 | +22.89% | +6.81% |
 Eternal LimitedETERNAL Open analysis | ₹3.00L | 692.13 | 0.00% | ₹3,349.00 | ₹585.00 | +38.79% | -2.82% |
Bajaj Auto LimitedBAJAJ-AUTO Open analysis | ₹2.86L | 24.74 | 1.44% | ₹17,243.72 | ₹2,982.84 | +36.35% | +34.94% |
 Eicher Motors LimitedEICHERMOT Open analysis | ₹2.00L | 34.66 | 1.13% | ₹6,632.00 | ₹1,463.00 | +31.54% | +21.41% |
 TVS Motor Company LimitedTVSMOTOR Open analysis | ₹1.95L | 56.76 | 0.30% | ₹16,296.00 | ₹1,058.00 | +33.46% | +64.54% |
 Samvardhana Motherson International LimitedMOTHERSON Open analysis | ₹1.70L | 38.55 | 0.31% | ₹35,244.00 | ₹1,076.00 | +16.66% | +77.56% |
Faze Three Limited, established in 1985, is primarily engaged in manufacturing and exports of end home textile products items like bathmats, rugs, blankets, throws, cushions, etc. The company has diversified its product mix across categories in the Home Textile segment and is also a direct exporter to top retail store chains in USA, UK and Europe. [1][2]
IndiaConsumer Cyclical
Is Faze Three Limited Shariah compliant?
Faze Three Limited is currently screened as Shariah Compliant under AAOIFI Shariah Standard No. 21. Business activities align with Shariah permissible sectors. Debt to Market Cap (27.12%) complies with AAOIFI threshold (≤ 33%).
What is Faze Three Limited's current valuation relative to peers?
Faze Three Limited trades at a P/E of 33.4x compared to the sector median of 26.8x, and a Price-to-Book of 2.2x.
Is the company financially healthy?
The company has a Debt-to-Equity ratio of 0.61x and a Net Debt to EBITDA ratio of 2.96x. Interest coverage is 3.1x.
What are the historical revenue and profit growth rates?
Over the past 5 years, revenue compounded at 11.4% while net profit growth averaged -6.1%.
Market data is informational and may be delayed. Shariah screening follows the displayed methodology. This is not investment advice.
Market data may be delayed. Quote date: 2026-10-16. Financial figures relate to their stated reporting periods. This information is for research and is not a recommendation to buy or sell.